Santai Song
- Oncology top 10%
- HER2/EGFR in Cancer Research 17
- Cancer Treatment and Pharmacology 17
- Colorectal Cancer Treatments and Studies 8
- Cancer Diagnosis and Treatment 7
- Bone health and treatments 6
- Cancer Cells and Metastasis 5
-
- Breast Cancer Treatment Studies 6
-
- Lung Cancer Treatments and Mutations 10
- Partner nations
- ChinaUnited StatesCzechia
In The Last Decade
Santai Song
62 papers receiving 599 citations
Peers
Comparison fields: 5 of 87
- Oncology 340
- Cancer Research 150
- Pulmonary and Respiratory Medicine 157
- Genetics 51
- Immunology 74
Countries citing papers authored by Santai Song
This map shows the geographic impact of Santai Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Santai Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Santai Song more than expected).
Fields of papers citing papers by Santai Song
This network shows the impact of papers produced by Santai Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Santai Song. The network helps show where Santai Song may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Santai Song, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 1 | |
| 2 | 2018 | 37 | |
| 3 | 2015 | 29 | |
| 4 | 2015 | 8 | |
| 5 | [Detection of circulating tumor cells and its clinical value for different stages and various subtypes of breast cancer]. | 2014 | 3 |
| 6 | 2014 | 3 | |
| 7 | 2014 | 48 | |
| 8 | 2013 | 3 | |
| 9 | [Efficacy and prognostic analysis of retreatment with trastuzumab-based therapy after multi-line targeted therapy resistance in HER2-positive metastatic breast cancer]. | 2013 | 3 |
| 10 | 2012 | 11 | |
| 11 | 2011 | 3 | |
| 12 | 2011 | 12 | |
| 13 | 2011 | 3 | |
| 14 | 2010 | 7 | |
| 15 | A Clinical Trial of Ca and Mg Mixture for Preventing Oxaliplatin-Induced Neurotoxicity | 2009 | 1 |
| 16 | [Phase III clinical study of zoledronic acid in the treatment of pain induced by bone metastasis from solid tumor or multiple myeloma]. | 2008 | 4 |
| 17 | 2008 | 5 | |
| 18 | 2007 | 72 | |
| 19 | [Expression of c-erbB2 protein and its relation to prognosis in 284 primary breast cancer patients]. | 2006 | 0 |
| 20 | 2004 | 5 |
About Santai Song
Santai Song is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 65 papers that have together received 608 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (17 papers), Cancer Treatment and Pharmacology (17 papers), Lung Cancer Treatments and Mutations (10 papers), Colorectal Cancer Treatments and Studies (8 papers), Cancer Diagnosis and Treatment (7 papers), Bone health and treatments (6 papers), Breast Cancer Treatment Studies (6 papers) and Cancer Cells and Metastasis (5 papers). The work is most often cited by research in Oncology (340 citations), Cancer Research (150 citations) and Pulmonary and Respiratory Medicine (157 citations). Santai Song has collaborated with scholars based in China, United States and Czechia. Frequent co-authors include Zefei Jiang, Shikai Wu, Bing Sun, Xiangying Meng, Shaohua Zhang, Zhou Huang, Ning Guo, Yuhua Song, Qian Lu and Liyong Chen.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.